Insulin Resistance in Atopic Dermatitis Patients
- Conditions
- Atopic Dermatitis
- Registration Number
- NCT05904509
- Lead Sponsor
- Bezmialem Vakif University
- Brief Summary
The aim of the study is to determine the relationship between insulin resistance and disease duration and severity of atopic dermatitis.
- Detailed Description
The aim of the study is to determine the relationship between insulin resistance and disease duration and severity of atopic dermatitis. EASI and SCORAD values and disease duration of atopic dermatitis patients are calculated during the examination. HOMA-IR blood test result is compared with the results.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
- Atopic dermatitis patients confirmed by a dermatologist
- patients younger than 2 years
- patients older than 80 years
- Atopic dermatitis patients without HOMA-IR result
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SCORAD index 12 months Severity scoring of atopic dermatitis is calculated for each patient in the study. 6 intensity items (erythema, edema/papulation, oozing/crusts, excoriations, lichenification, dryness); 2 subjective symptoms(itch, sleeplessness); body surface area are studied. Max score is 103.
HOMA-IR 12 months Patients' blood test show the result of fasting insulin (microU/L) x fasting glucose (mmol/L)/22.5
Duration of the disease 12 months The time from the first onset of symptoms of the disease to the present. The relationship between insulin resistance and disease duration is examined
EASI index 12 months Eczema Area and Severity Index is calculated for each patient in the study. Body surface area, 4 intensity items(erythema, induration, excoriation, lichenification) are studied. Max score is 72.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Bezmialem Vakif University Hospital
🇹🇷Istanbul, Turkey